Clinical Trials Browser

Unknown × Lymphoma × aldesleukin × Clear all

NCT00006100 2013-12-18

Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma

Phase 1 Unknown

Hodgkin Disease, Lymphoma